CN | EN
Zidovudine/Lamivudine Tablet (60 tablets)
简 介


Drug Name:Zidovudine/Lamivudine Tablet

Ingredient:  This product is compound, each containing 300mg of zidovudine and lamivudine 150mg.

Property: The product is capsule type film-coated tablet, removing wrapper show white or class after white.

Indications:  This product alone or with other antiretroviral drugs in combination for the treatment of human immunodeficiency virus (HIV) infection.

Specification: Each tablet contains 300mg of zidovudine and lamivudine 150mg.

Usage and dosage:

The tablet is taken by mouth as a tablet. The normal adult dose is one tablet, two times a day. It can be taken with food, or between meals.

Adults and Adolescents Weighing ≥30 kg

The recommended oral dose of it in HIV-1-infected adults and adolescents weighing greater than or equal to 30 kg is 1 tablet (containing 150 mg of lamivudine and 300 mg of zidovudine) twice daily.

Pediatric Patients

The recommended oral dosage of scored tablets for pediatric patients who weigh greater than or equal to 30 kg and for whom a solid oral dosage form is appropriate is 1 tablet administered twice daily.

Taboo:  Patients who are allergic to lamivudine, zidovudine or to any ingredient in this preparation are disable to the product.

Storage:  Dark, sealed, stored at below 30 ℃.

Packing:  Packing dual-soft aluminum, 10 / plate, 6 plates / box; High-density polyethylene plastic bottles of 60 tablets / bottle.

Valid Period:  24 months

Approval Number:  国药准字H20113129

Executive standard:  State Food and Drug Administration standards YBH01082011

Manufacturers:  Anhui Biochem Bio-Pharmaceutical Co., Ltd.